What APOVERLAG does

APOVERLAG (legal name: Österreichische Apotheker-Verlagsgesellschaft m.b.H.) is a Vienna-based, privately held publishing and information services company serving the Austrian pharmaceutical sector. Founded in 1946 and jointly owned 50/50 by the Österreichischer Apothekerverband and the Verband Angestellter Apotheker Österreichs (VAAÖ), the company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—that collectively cover the pharmacy-to-physician-to-hospital value chain. Its core assets include AVS Software (Austria's leading pharmacy management system), Diagnosia Enterprise (a web-based clinical decision support platform serving 90+ hospitals and nursing facilities with 7M+ monthly data queries), and the Austria Codex Online pharmaceutical database covering 110,000+ drug articles.

The company's technology stack comprises cloud-hosted web applications and mobile apps integrating with hospital KIS/PDMS systems via documented REST-API (JSON) and GET-parameter interfaces. Diagnosia Enterprise sources clinical evidence from Medbase (a Karolinska Institut spin-off, ISO-certified), AGES, and EMA. The portfolio also includes professional journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), continuing education platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, Warenverzeichnis), the ApoShop e-commerce storefront, and the ApoVerlag Couponing system operating across 1,400+ pharmacy interfaces.

APOVERLAG generates revenue through six distinct streams: recurring database and software subscriptions (Austria Codex Online, Diagnosia Enterprise, AVS Software), software licenses and SaaS, print publications, direct e-commerce product sales via ApoShop, advertising in owned professional media, and freemium training/continuing education. Go-to-market combines direct-to-consumer self-service through ApoShop, in-house enterprise sales (Verkaufsabteilung) for AVS and Diagnosia Enterprise, certified software house partners for hospital integration, and the association ownership structure that delivers near-universal distribution across the Austrian pharmacy profession. The company serves four primary vertical segments—pharmacies, physician practices, hospitals, and pharmaceutical companies—exclusively within the Austrian domestic market.

Name

APOVERLAG

Legal name

Österreichische Apotheker-Verlagsgesellschaft m.b.H.

Website

https://apoverlag.at

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

51–100 employees

Short description

APOVERLAG is a Vienna-based, pharmacist-association-owned publishing and information services company (founded 1946) providing pharmacy software (AVS), clinical decision support for 90+ hospitals (Diagnosia Enterprise), pharmaceutical databases, professional journals, and continuing education to the Austrian healthcare sector.

Ownership category

akta.pro rank

Product category

Pharmaceutical Information & Pharmacy Software

NAICS

Software Publishers (51321)

akta.pro primary industry

ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)

akta.pro secondary industries

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Pharmaceutical information databases
• Pharmacy management software
• Clinical decision support systems
• Medical publishing services
• Healthcare professional education

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Pharmaceutical Database Subscriptions: Subscription-based access to Austria Codex Online, Austria Codex KHIX², Warenverzeichnis Online, AMSE, and other pharma databases. Offered as modular, combinable subscriptions for pharmacies, hospitals, physician practices, and pharmaceutical companies. Revenue is recurring with periodic (monthly/annual) billing.
2. Software Licenses and SaaS: Licensing of AVS Software (pharmacy management), Diagnosia Enterprise (clinical decision support), and AVS One App. Diagnosia Enterprise is offered as standalone or integrated solutions for hospitals, with tiered modules (Basic, Check, Grav&Lact, Allergy, Dose).
3. Print Publications and Journals: Sale of pharmaceutical journals (ÖAZ – Österreichische Apotheker-Zeitung, appearing bi-weekly; pka-Magazin, appearing six times annually; DA – Deine Apotheke customer magazine), pharmaceutical reference works (Taxbehelf, Warenverzeichnis print editions, pharmaceutical handbooks), and prescription reference tables. Offered as subscriptions or individual purchases.
4. eCommerce – Product Sales: Direct sales of pharmacy supplies, consumables, packaging, reference tables, handbooks, and pharmaceutical documentation through the ApoShop online store (shop.apoverlag.at). Includes one-time purchases and consumable restocking.
5. Advertising and Promotion Services: Advertising and promotional placement in print journals (ÖAZ, pka-Magazin, DA – Deine Apotheke), the Warenverzeichnis WEB-Link promotional service (manufacturer product linking), and advertising forms for pharmaceutical companies targeting pharmacists and physicians.
6. Training and Continuing Education: Continuing education platforms (ApoVerlag Campus, ApoVerlag PKA Campus, Diagnosia Campus) offering free training content for pharmacists, PKA, and physicians, earning DFP/AFP/FFP certification credits. Some programs are free; others may be bundled into subscriptions.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Core offering

APOVERLAG provides pharmaceutical information databases, pharmacy management software (AVS), clinical decision support platforms (Diagnosia Enterprise), and professional publishing for the Austrian healthcare sector. The company operates three brands—ApoVerlag, AustriaCodex, and Diagnosia—covering drugs, pricing references, clinical content, and digital workflows for pharmacies, physicians, hospitals, and pharmaceutical manufacturers. It also publishes the ÖAZ and pka-Magazin journals and offers continuing education (ApoVerlag Campus, Diagnosia Campus) for healthcare professionals.

Product overview

APOVERLAG operates as a comprehensive pharmaceutical information and publishing company with three main brands: AustriaCodex (drug databases and reference materials), ApoVerlag (complete solutions for pharmacies), and Diagnosia (digital solutions for medical professionals). The portfolio includes core software products like AVS pharmacy software and Diagnosia Enterprise, pharmaceutical databases (Austria Codex Online, Warenverzeichnis, KHIX²), professional publications (ÖAZ journal, pka-Magazin, DA magazine), educational platforms (ApoVerlag Campus, Diagnosia Campus), print reference works (Taxbehelf, pharmaceutical handbooks), and digital tools (Apps, couponing, on-duty displays). The platform-plus-modules architecture is evident in Diagnosia Enterprise with its modular offering (Basic, Check, Allergy, Gravidität & Laktation, Dose modules) and AustriaCodex with its combinable database modules.

Differentiator

Problem solved

Functional benefit

Brands

• ApoVerlag: Brand providing complete solutions for Austrian pharmacies, including pharmacy software AVS, specialist media (ÖAZ, pka-Magazin, DA – Deine Apotheke), pharmaceutical data, print works, and digital solutions.
• AustriaCodex
• Diagnosia

Products and services

• Diagnosia Enterprise Web-based evidence-based clinical decision support platform for hospitals and nursing facilities, providing drug Fachinformation, safety, dosages, treatment options, interaction checks, UAW analysis, pregnancy/lactation guidance, allergy cross-reaction checking, and dose adjustments for renal/hepatic impairment. Integrated via REST-API (JSON) or GET-parameter interfaces into hospital KIS/PDMS. Used by 90+ Austrian hospitals and nursing facilities with 7 million+ monthly data queries.
• Diagnosia App Mobile application providing fast medication search with specialist and reimbursement information overview, and drug interactions display. Targeted at physicians for daily clinical workflow use and explicitly does not collect patient health data.
• Diagnosia Campus Free continuing education platform for physicians featuring live webinars, e-learnings, podcasts, and DFP points collection.
• Austria Codex Online
• AVS Software
• ÖAZ – Österreichische Apotheker-Zeitung
• pka-Magazin
• DA – Deine Apotheke
• ApoVerlag Campus
• ApoVerlag PKA Campus
• ApoVerlag Couponing
• Warenverzeichnis (Article Directory)
• Spezialitäteninfo²
• AMSE Arzneischnellerkennung Online
• Taxbehelf
• ApoShop
• Warenverzeichnis WEB-Link

Quantifiable outcome

• 90+ Austrian hospitals and nursing facilities rely on Diagnosia Enterprise daily
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• MedbasecoreTechnology or IntegrationMedbase (a Karolinska Institut spin-off, ISO-certified company based in Finland) is the primary data source for Diagnosia Enterprise's clinical decision support content. Medbase provides evidence-based drug safety, efficacy, and dosage information including interactions, UAW analysis, pregnancy/lactation guidance, allergy cross-reactions, and dose adjustments for renal/hepatic impairment. This data partnership forms the clinical core of Diagnosia Enterprise, used by 90+ Austrian hospitals.
• Software Houses (KIS/PDMS Integration Partners)coreImplementation/ SI/ Consulting PartnerAPOVERLAG works with certified software houses (SWH) to integrate Diagnosia Enterprise via REST-API (JSON format) or GET-parameter interfaces into hospital KIS (Hospital Information Systems) and PDMS (Patient Data Management Systems). Implementation follows a structured process: contract clarification, test account/token issuance, SWH-led integration, and go-live with user onboarding.
• Österreichischer Apothekerverband & VAAÖ (Parent Organizations)coreStrategic or Co-development PartnerAPOVERLAG is co-owned 50/50 by the Österreichischer Apothekerverband (Austrian Pharmacists Association – representing independent pharmacists) and the Verband Angestellter Apotheker Österreichs (VAAÖ – Association of Employed Pharmacists Austria). Both parent organizations are based at Spitalgasse 31, 1090 Vienna. They co-publish the ÖAZ journal and represent the professional interests of Austrian pharmacists.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• DAKOS Datenkommunikations GmbH (DAKOS): German provider of pharmacy management systems, PVS/Praxis and reimbursement solutions comparable to APOVERLAG's AVS Software and tax/pricing tools.
• ifap Service-Institut für Ärzte und Apotheker: Provider of drug databases and clinical decision support tools used by physicians and pharmacies in Germany, including interaction checks and reference data. Direct comparable to Austria Codex and Diagnosia Enterprise offerings.
• mmi Medizinische Medien Informations GmbH: Germany-based publisher of pharmaceutical databases, clinical decision support and medication management software (e.g., ifap index, PharmaMMI). Direct competitor to APOVERLAG's Austria Codex and Diagnosia Enterprise products in DACH ePrescribing and medication workflow software.
• ABDATA Pharma-Daten-Service (ABDA): Operator of Germany's central pharmaceutical article database (ABDA-Artikelstamm) used in pharmacy systems. Compares directly to APOVERLAG's Warenverzeichnis; APOVERLAG's AVS Software even integrates ABDA's article master as a Germany bridge.

Regional players

• Documed (Swiss Drug Compendium): Swiss pharmaceutical documentation firm operating the official Swiss drug reference (compendium.ch). Closely comparable as a national drug compendium and reference publisher for healthcare professionals.
• HCI Solutions (Galexis/HDG-Data): Swiss publisher of pharmaceutical indexing, drug information and pharmacy data (Index Therapeuticus, compendium.ch). Operates a model analogous to APOVERLAG's Austria Codex Warenverzeichnis but in the Swiss market.

Broad incumbents

• CompuGroup Medical (CGM): Large European healthcare software incumbent offering pharmacy IT (e.g., PHARMACY, WinApothek), ePrescribing, hospital information systems and clinical decision support. Operates across DACH with broader portfolio and scale than APOVERLAG's pharmacy-focused stack.
• Elsevier ClinicalPath / ClinicalKey Drugs: Elsevier's clinical decision support and drug reference portfolio (ClinicalKey, Gold Standard). Targets hospital drug information and formulary workflows parallel to Austria Codex KHIX² and Diagnosia Enterprise.
• Wolters Kluwer Clinical Solutions (Lexicomp/UpToDate/Medi-Span): Global clinical decision support and drug reference vendor (Lexicomp, Medi-Span, UpToDate Lexidrug). Competes with Diagnosia Enterprise at the hospital CDS level and could enter Austrian hospital integrations.

Emerging players

• ID Information & Dokumentation im Gesundheitswesen: Provider of specialized drug information and CDSS tools that target hospital and pharmacy drug workflow use cases similar to Austria Codex KHIX² and Diagnosia Enterprise modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/apoverlag

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APOVERLAG